Showing results (291-300 of 301) with videos related to
Sort By:
Pageof 31
Physical Review Letters|November 13, 2023
Strong Evidence for ^{9}N and the Limits of Existence of Atomic NucleiR J Charity, J Wylie, S M Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.Cancer Treatment Reports|July 1, 1976
Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lungJ H Edmonson, S W Lagakos, O S Selawry, et al.Physical Review Letters|April 13, 2019
First Observation of Unbound ^{11}O, the Mirror of the Halo Nucleus ^{11}LiT B Webb, S M Wang, K W Brown, et al.Leukemia Research|May 30, 2001
Diagnostic criteria and classification of mastocytosis: a consensus proposalP Valent, H P Horny, L Escribano, et al.Physical Review Letters|January 14, 2022
First Observation of the Four-Proton Unbound Nucleus ^{18}MgY Jin, C Y Niu, K W Brown, et al.Bioorganic & Medicinal Chemistry Letters|February 24, 2001
The identification of alpha-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinaseJ M Bennett, A D Campbell, A J Campbell, et al.Leukemia|June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?J Schanz, H Tüchler, F Solé, et al.The American Journal of Medicine|October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology GroupW D Dewys, C Begg, P T Lavin, et al.Antiviral Chemistry & Chemotherapy|November 26, 1999
The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinaseM R Attwood, J M Bennett, A D Campbell, et al.Pageof 31